<?xml version='1.0' encoding='utf-8'?>
<chapter num="16" heading="Portable Drug Kits for Licensed Home Health Agencies, Hospices, and Home Infusion Providers Licensed as Residential Services Agencies" title_num="10" subtitle_num="34">
  <regulation prefix="Regulation" num=".01" heading="Definitions.">
    <paragraph num="A.">
      <text>In this chapter, the following terms have the meanings indicated.</text>
    </paragraph>
    <paragraph num="B.">
      <text>Terms Defined.</text>
      <paragraph num="(1)">
        <text>“Committee” means, in this chapter, a joint committee of representatives from the Board of Pharmacy and the Board of Nursing.</text>
      </paragraph>
      <paragraph num="(2)">
        <text>“Portable drug kit” means a container comprising prescription drugs and other emergency medical supplies or drugs for use in licensed home health and licensed hospice settings, and by home infusion providers licensed as residential services agencies.</text>
      </paragraph>
      <paragraph num="(3)">
        <text>“Prescription protocol” means an order for a portable drug kit signed by the medical director of a licensed home health agency, licensed general hospice, or a home infusion provider licensed as a residential services agency.</text>
      </paragraph>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".02" heading="Requirements for Prescription Protocol.">
    <text>Before distributing a portable drug kit, the pharmacist shall ensure that the prescription protocol includes:</text>
    <paragraph num="A.">
      <text>The name, strength, and quantity of a drug to be included in the portable drug kit;</text>
    </paragraph>
    <paragraph num="B.">
      <text>The name of the receiving agency or designated agent;</text>
    </paragraph>
    <paragraph num="C.">
      <text>The directions for use;</text>
    </paragraph>
    <paragraph num="D.">
      <text>Conditions for use;</text>
    </paragraph>
    <paragraph num="E.">
      <text>Contraindications for use; and</text>
    </paragraph>
    <paragraph num="F.">
      <text>The signature, printed name, and telephone number of the physician authorizing the kit.</text>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".03" heading="Records.">
    <text>A pharmacist shall:</text>
    <paragraph num="A.">
      <text>File the prescription protocol in a readily retrievable manner;</text>
    </paragraph>
    <paragraph num="B.">
      <text>Document the:</text>
      <paragraph num="(1)">
        <text>Date of distribution of the portable drug kit,</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Name of the person or agency to whom the kit is delivered, and</text>
      </paragraph>
      <paragraph num="(3)">
        <text>Date of delivery for each kit distributed;</text>
      </paragraph>
    </paragraph>
    <paragraph num="C.">
      <text>File an administration record for all drugs administered from a kit upon return of the kit to the pharmacy; and</text>
    </paragraph>
    <paragraph num="D.">
      <text>Notify the Board of Pharmacy before distributing portable drug kits under this chapter.</text>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".04" heading="Requirements of the Portable Drug Kit.">
    <paragraph num="A.">
      <text>The pharmacist shall ensure that the portable drug kit:</text>
      <paragraph num="(1)">
        <text>Is sealed with a tamper evident tag or other means for detecting entry to the kit;</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Displays on the outside of the kit:</text>
        <paragraph num="(a)">
          <text>A serial number unique to the kit;</text>
        </paragraph>
        <paragraph num="(b)">
          <text>An expiration date which reflects the earliest expiration date of any item contained in the kit;</text>
        </paragraph>
        <paragraph num="(c)">
          <text>The contents of the kit;</text>
        </paragraph>
        <paragraph num="(d)">
          <text>That the contents are or are not sterile;</text>
        </paragraph>
        <paragraph num="(e)">
          <text>The legend “To be returned to the pharmacy within 5 days of breaking seal, with a completed administration record or prescription enclosed”; and</text>
        </paragraph>
        <paragraph num="(f)">
          <text>Storage requirements for the contents;</text>
        </paragraph>
      </paragraph>
      <paragraph num="(3)">
        <text>Contains:</text>
        <paragraph num="(a)">
          <text>Only prescription drugs and nonprescription items approved for the kit by a committee as defined in Regulation .01B(1) of this chapter;</text>
        </paragraph>
        <paragraph num="(b)">
          <text>A temperature monitor to indicate maintenance of proper storage conditions; and</text>
        </paragraph>
        <paragraph num="(c)">
          <text>A written administration record to be completed by the licensed health care provider using the kit, which includes the administration record indicating:</text>
          <paragraph num="(i)">
            <text>The name of the patient,</text>
          </paragraph>
          <paragraph num="(ii)">
            <text>The name of the prescriber,</text>
          </paragraph>
          <paragraph num="(iii)">
            <text>Drug name, form, and dosage,</text>
          </paragraph>
          <paragraph num="(iv)">
            <text>Date the drug was used or wasted,</text>
          </paragraph>
          <paragraph num="(v)">
            <text>The reason for administration or wastage of the drug, and</text>
          </paragraph>
          <paragraph num="(vi)">
            <text>The name of the licensed health care provider utilizing the kit;</text>
          </paragraph>
        </paragraph>
      </paragraph>
      <paragraph num="(4)">
        <text>Displays or includes written information inside the kit listing contraindications to use of the kit; and</text>
      </paragraph>
      <paragraph num="(5)">
        <text>Does not contain a controlled dangerous substance.</text>
      </paragraph>
    </paragraph>
    <paragraph num="B.">
      <text>A pharmacist shall only distribute a portable drug kit which complies with the requirements of this chapter.</text>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".05" heading="Contents of Portable Drug Kit.">
    <text>The committee shall review annually the approved prescription drugs and nonprescription items to ensure that the contents of a portable drug kit are appropriate.</text>
  </regulation>
  <regulation prefix="Regulation" num=".06" heading="Distribution of Portable Drug Kits.">
    <text>Portable drug kits may only be distributed to licensed health care providers who are authorized by law to administer the contents of a portable drug kit.</text>
  </regulation>
  <annotations>
    <annotation type="Authority">Health Occupations Article, §12-205, Annotated Code of Maryland</annotation>
    <annotation type="History" subtype="Administrative History">Effective date: September 6, 1999 (26:18 Md. R. 1376)</annotation>
    <annotation type="History" subtype="Administrative History">Regulations .01—.04 amended effective April 16, 2001 (28:7 Md. R. 690)</annotation>
    <annotation type="History" subtype="Administrative History">Regulations .05 and.06 adopted effective April 16, 2001 (28:7 Md. R. 690)</annotation>
  </annotations>
</chapter>